POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY
- PMID: 28704103
- DOI: 10.4158/EP171813.OR
POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY
Abstract
Objective: To assess the prevalence and characteristics of patients with type 1 diabetes (T1D) who dose bolus insulin postprandial (PostP) versus preprandial (PreP).
Methods: Data for this cross-sectional study were obtained from 21,533 participants in the T1D Exchange Registry. Data were drawn from the enrollment questionnaire. Patients who dosed 'immediately before meal' or 'several minutes before meal' were classified as PreP. Patients who dosed 'during meal' or 'after meal' were classified as PostP. Data reported (PostP vs. PreP) are mean ± SD and percentage, as appropriate.
Results: After exclusion of patients who did not answer the dose-timing question or who selected 'not given regularly' or 'depends on glucose level prior to meal,' (4,229 of 25,762), 21,533 patients were included in the study. Ninety-nine percent of patients used rapid-acting insulin analogues; 32% dosed insulin PostP. Compared to PreP, children <18 years of age dosing PostP were characterized by higher glycated hemoglobin (HbA1c) (8.7 ± 1.5% [72 ± 16.4 mmol/mol] vs. 8.4 ± 1.7% [68 ± 18.6 mmol/mol]), larger insulin dose (1.2 ± 0.7 IU/kg/day vs. 1.1 ± 0.7 IU/kg/day), greater prevalence of history of hypoglycemia, and diabetic ketoacidosis. Adults who dosed PostP were characterized by younger age (33.0 ± 15.3 years vs. 39.5 ± 16.6 years), higher HbA1c (8.3 ± 1.5% [67 ± 16.4 mmol/mol] vs. 7.8 ± 1.5% [62 ± 16.4 mmol/mol]), and larger insulin dose (1.0 ± 0.6 IU/kg/day vs. 0.9 ± 0.5 IU/kg/day) than PreP.
Conclusion: This study reveals that a large proportion of patients dose bolus insulin PostP. Despite the use of current rapid-acting insulin analogues, patients who dose PostP are characterized by poorer glycemic control in all patients and a greater prevalence of history of severe hypoglycemia and diabetic ketoacidosis in children.
Abbreviations: BMI = body mass index; CGM = continuous glucose monitoring; DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; PostP = postprandial; PreP = preprandial; SMBG = self-monitored blood glucose; T1D = type 1 diabetes.
Comment in
-
THE TIMING OF MEAL INSULIN ADMINISTRATION.Endocr Pract. 2017 Dec;23(12):1482-1484. doi: 10.4158/EP-2017-0073. Epub 2017 Nov 16. Endocr Pract. 2017. PMID: 29144810 No abstract available.
Similar articles
-
Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry.Diabetes Care. 2013 Nov;36(11):3573-7. doi: 10.2337/dc12-2643. Epub 2013 Sep 11. Diabetes Care. 2013. PMID: 24026543 Free PMC article.
-
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10. Diabetes Care. 2014. PMID: 25011947 Free PMC article.
-
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.Diabetes Care. 2015 Jun;38(6):971-8. doi: 10.2337/dc15-0078. Diabetes Care. 2015. PMID: 25998289
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps.Nutrients. 2021 Oct 11;13(10):3558. doi: 10.3390/nu13103558. Nutrients. 2021. PMID: 34684559 Free PMC article.
Cited by
-
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.Diabetes Care. 2021 Feb;44(2):448-455. doi: 10.2337/dc20-1017. Epub 2020 Dec 16. Diabetes Care. 2021. PMID: 33328285 Free PMC article. Clinical Trial.
-
Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes.Front Pediatr. 2021 Apr 30;9:679484. doi: 10.3389/fped.2021.679484. eCollection 2021. Front Pediatr. 2021. PMID: 33996702 Free PMC article. Review.
-
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis.Diabetes Ther. 2017 Dec;8(6):1319-1329. doi: 10.1007/s13300-017-0317-9. Epub 2017 Oct 23. Diabetes Ther. 2017. PMID: 29063510 Free PMC article.
-
Ultrafast acting insulin analog - a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients - case reports.Pediatr Endocrinol Diabetes Metab. 2021;27(4):305-310. doi: 10.5114/pedm.2022.112621. Pediatr Endocrinol Diabetes Metab. 2021. PMID: 35114772 Free PMC article.
-
Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes.Clin Diabetes. 2021 Oct;39(4):347-357. doi: 10.2337/cd20-0117. Clin Diabetes. 2021. PMID: 34866778 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous